Jeff Lewis Takeda

Jeff Lewis has worked in pharmaceutical manufacturing for over 16 years. Starting as a compliance investigator and problem solver in plasma derived therapies for Baxter; he has expanded to biologics and small molecule process investigations through divestments and acquisitions from Baxter to Baxalta to Shire, and now Takeda. In this time he has developed a strong technical problem solving (Six Sigma Black Belt) and Quality Compliance background, and is an expert if resolving deviations related to numerous manufacturing processes. Currently, as the head of Takedas' Global RAPID Investigation team he leverages this background to lead the team to quick and effective resolution of significant product issues; minimizing potential risk to patients and regulatory reputation.